We continue to add new products internationally. We have approximately 250 applications for approval of generic drugs pending with health agencies around the world and received more than 70 generic drug approvals worldwide in 2002. During 2002, we expanded our presence in Europe and USA. We decided to acquire this small business for a moderate price as a foundation to grow our operations in Europe and USA. We have hired a top management and research team that we believe can quickly make this business a market leader in Europe and USA. We believe that demand for generic drugs is going to increase worldwide and that our global subsidiaries will position for growth.